Cosmo Pharmaceuticals N.V. (COPN.SW) SIX

105.20

+1.2(+1.15%)

Updated at December 23 05:31PM

Currency In CHF

Valuation

Market Cap1.11B
Enterprise Value1.07B
P/E Ratio32.7
PEG Ratio-0.55
Price/Sales Ratio9.92
Price/Book Ratio3.93
Enterprise/Revenue9.66
Enterprise/EBITDA23.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.3
Operating Margin0.33

Management Effectiveness

Return On Assets0.09
Return On Equity0.12

Income Statement

Revenue266.79M
Revenue/Share11.45
Gross Profit246.92M
EBITDA165.71M
Net Income133.24M
Diluted EPS8.12

Balance Sheet

Total Cash126.63M
Total Cash/Share3.26
Total Debt2.7M
Total Debt/Equity0.01
Current Ratio3.84
Book Value Per Share29.33

Price History

52-Week Change65.15
52-Week High108
52-Week Low41.6
Moving Average 50 Days75.19
Moving Average 200 Days62.21

Statistics

Average Volume47,070
Shares Outstanding15.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2.07
Trailing Annual Dividend Yield1.82
Payout Ratio1.02
Last Split FactorN/A
Last Split DateN/A